# Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS)

> **NCT00677768** · — · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 475 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis
- Lou Gehrig's Disease
- Primary Lateral Sclerosis
- Nervous System Diseases
- Hereditary Spastic Paraparesis

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT00677768
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 475 (ACTUAL)
- **Last updated:** 2016-06-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00677768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00677768, "Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00677768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*